FDA Warning Letter — Reproductive Technologies, Inc.
The FDA took a Warning Letter action against Reproductive Technologies, Inc. on November 6, 2019 (Berkeley, CA). The action was issued by CBER and concerns biologics products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Reproductive Technologies, Inc.
- Date
- November 6, 2019
- Fiscal Year
- 2020
- Product Type
- Biologics
- Center
- CBER
- Location
- Berkeley, CA (United States)